{"id":708992,"date":"2026-06-10T00:00:00","date_gmt":"2026-06-10T00:00:00","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/?p=708992"},"modified":"2026-06-10T02:43:27","modified_gmt":"2026-06-10T02:43:27","slug":"lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/","title":{"rendered":"LVP Pharma continues accumulation spree with EGP 847 mn Rameda share purchase"},"content":{"rendered":"

LVP Pharma upped its stake in EGX-listed pharma giant Rameda to 31.5%, effectively buying out Equinox Pharma Holdin<\/strong>g in an EGP 847 mn transaction<\/strong>, according to a bourse disclosure (pdf)<\/a>. LVP acquired some 167 mn shares \u2014 good for an 8.3% stake in Rameda \u2014 at EGP 5.07 each, representing a 3.1% markdown (by our math) to Rameda\u2019s Monday close. Equinox, which had been trimming its position since March, \u201chas [now] sold its entire stake in Rameda,\u201d Rameda CFO Mohamed Aboamira tells EnterpriseAM.<\/p>\n

LVP is now within touching distance of the MTO line. <\/strong>Under capital market rules, investors that cross the 33.33% threshold are required to launch a mandatory tender offer (MTO) for the remaining shares. This means any further buying would likely bring the MTO rule into play \u2014 a mechanism that exists to give minority shareholders the right to exit at a fair price once a single investor approaches control.<\/p>\n

IN CONTEXT- <\/strong>The latest purchase caps a months-long accumulation spree. LVP nearly doubled its exposure to the pharma giant in a transaction valued at EGP 1.1 bn back in March<\/a>. The firm bought a total of 223 mn shares, including 220 mn from Equinox Pharma Holding, at EGP 5.1 apiece, making it Rameda\u2019s largest shareholder after a flurry of sizable share purchases in the preceding weeks.<\/p>\n

Expect more buying ahead: <\/strong>LVP is expected to increase its stake further in the future, Aboamira says, noting the firm views Rameda as \u201cthe ideal vehicle to drive their healthcare strategy.\u201d Whether that eventually takes LVP across the MTO threshold is undecided, though newly appointed Chairman Sherif El Akhdar has made it a top priority, the CFO adds.<\/p>\n

A new board<\/strong>: <\/strong>El Akhdar \u2014 who founded LimeVest, the healthcare private equity firm that owns LVP Pharma \u2014 was appointed non-executive chairman<\/a> of Rameda\u2019s board of directors last week.<\/p>\n

Molecules first:<\/strong> Rather than corporate acquisitions, Rameda is strictly targeting high-margin product and molecule acquisitions that can be immediately integrated onto existing production lines with zero capital expenditure (capex), Aboamira says. These products typically carry gross margins above 70% and EBITDA margins around 50%, providing a massive boost to the bottom line.<\/p>\n

\u201cOur next big move is regional expansion<\/strong>,\u201d Aboamira notes. \u201cThis partnership grants us the access required to establish secondary packaging facilities and scale up exports to Saudi Arabia and other regional markets.\u201d<\/p>\n

Who else sits at the cap table:<\/strong> The PIF\u2019s Saudi Seventh Investment Co. owns 11% of Rameda, while the Kuwait Investment Authority\u2019s Ekuity B.V holds 10%, as per the company\u2019s 1Q shareholding disclosure (pdf)<\/a> dated 5 April 2026. With LVP\u2019s stake now at 31.5%, the three largest institutional holders together account for just over half of the company, and the rest of the shares are free floating.<\/p>\n

A snapshot of Rameda\u2019s 2025 earnings:<\/strong> Revenues jumped 48% y-o-y<\/a> to EGP 4.1 bn, though net income fell 22% to EGP 313 mn on surging financing costs and a one-off EGP 99 mn provision. That pressure is already easing. \u201cOur finance costs have now dropped to roughly 20% from 28% at the beginning of last year,\u201d he notes, adding that a reversal of the provision should give the company\u2019s bottom line \u201csignificant room to breathe\u201d this year.<\/p>\n

ADVISORS-<\/strong> Al Ahly Pharos quarterbacked the transaction.<\/p>\n","protected":false},"excerpt":{"rendered":"

The purchase caps a months-long accumulation spree that has cemented LVP as the pharma giant\u2019s largest shareholder<\/p>\n","protected":false},"author":1,"featured_media":708993,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[7363],"tags":[72,9068,7128,427,12584],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-708992","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ma-watch","tag-enterpriseam","tag-ma","tag-ma-watch","tag-pharma","tag-rameda","wpautop","entry"],"acf":{"mongo_id":"b034ab1f-6cb5-4549-a2e4-cb1fc6287773","order":"4","is_powered_by":false,"story_type":"1","photo_url":"https:\/\/ent.news\/2024\/3\/1743.jpg","photo_position":"above","homepage_title":"","full_issue_title":"Doubling down on pharma","related_issue":[708987],"teaser":"The purchase caps a months-long accumulation spree that has cemented LVP as the pharma giant\u2019s largest shareholder"},"yoast_head":"\nLVP Pharma continues accumulation spree with EGP 847 mn Rameda share purchase - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LVP Pharma continues accumulation spree with EGP 847 mn Rameda share purchase\" \/>\n<meta property=\"og:description\" content=\"The purchase caps a months-long accumulation spree that has cemented LVP as the pharma giant\u2019s largest shareholder\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-10T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-10T02:43:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/ent.news\/2024\/3\/1743.jpg?fit=%2C&ssl=1\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"LVP Pharma continues accumulation spree with EGP 847 mn Rameda share purchase\",\"datePublished\":\"2026-06-10T00:00:00+00:00\",\"dateModified\":\"2026-06-10T02:43:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/\"},\"wordCount\":532,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2024\/3\/1743.jpg?fit=%2C&ssl=1\",\"keywords\":[\"EnterpriseAM\",\"M&A\",\"M&A Watch\",\"pharma\",\"Rameda\"],\"articleSection\":[\"M&A WATCH\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/\",\"name\":\"LVP Pharma continues accumulation spree with EGP 847 mn Rameda share purchase - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2024\/3\/1743.jpg?fit=%2C&ssl=1\",\"datePublished\":\"2026-06-10T00:00:00+00:00\",\"dateModified\":\"2026-06-10T02:43:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/ent.news\/2024\/3\/1743.jpg?fit=%2C&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/ent.news\/2024\/3\/1743.jpg?fit=%2C&ssl=1\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LVP Pharma continues accumulation spree with EGP 847 mn Rameda share purchase\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"LVP Pharma continues accumulation spree with EGP 847 mn Rameda share purchase - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/","og_locale":"en_US","og_type":"article","og_title":"LVP Pharma continues accumulation spree with EGP 847 mn Rameda share purchase","og_description":"The purchase caps a months-long accumulation spree that has cemented LVP as the pharma giant\u2019s largest shareholder","og_url":"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2026-06-10T00:00:00+00:00","article_modified_time":"2026-06-10T02:43:27+00:00","og_image":[{"url":"https:\/\/i0.wp.com\/ent.news\/2024\/3\/1743.jpg?fit=%2C&ssl=1","type":"","width":"","height":""}],"author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"LVP Pharma continues accumulation spree with EGP 847 mn Rameda share purchase","datePublished":"2026-06-10T00:00:00+00:00","dateModified":"2026-06-10T02:43:27+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/"},"wordCount":532,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2024\/3\/1743.jpg?fit=%2C&ssl=1","keywords":["EnterpriseAM","M&A","M&A Watch","pharma","Rameda"],"articleSection":["M&A WATCH"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/","url":"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/","name":"LVP Pharma continues accumulation spree with EGP 847 mn Rameda share purchase - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/#primaryimage"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2024\/3\/1743.jpg?fit=%2C&ssl=1","datePublished":"2026-06-10T00:00:00+00:00","dateModified":"2026-06-10T02:43:27+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/#primaryimage","url":"https:\/\/i0.wp.com\/ent.news\/2024\/3\/1743.jpg?fit=%2C&ssl=1","contentUrl":"https:\/\/i0.wp.com\/ent.news\/2024\/3\/1743.jpg?fit=%2C&ssl=1"},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2026\/06\/10\/lvp-pharma-continues-accumulation-spree-with-egp-847-mn-rameda-share-purchase\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"LVP Pharma continues accumulation spree with EGP 847 mn Rameda share purchase"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":"https:\/\/i0.wp.com\/ent.news\/2024\/3\/1743.jpg?resize=600%2C400&ssl=1","featured_image_src_square":"https:\/\/i0.wp.com\/ent.news\/2024\/3\/1743.jpg?resize=600%2C600&ssl=1","author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/ent.news\/2024\/3\/1743.jpg?fit=%2C&ssl=1","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":544524,"url":"https:\/\/enterpriseam.com\/egypt\/2022\/03\/08\/qatari-dairy-firm-baladna-acquires-5-of-juhayna-compass-ups-share-in-rameda\/","url_meta":{"origin":708992,"position":0},"title":"Qatari dairy firm Baladna acquires 5% of Juhayna + Compass ups share in Rameda","author":"enterpriseam admin","date":"8 March 2022","format":false,"excerpt":"Qatar\u2019s Baladna acquires 5% stake in Juhayna: Qatari dairy firm Baladna has acquired a 5% stake (47.1 mn shares) in leading Egyptian dairy company Juhayna (JUFO) for EGP 285.8 mn, the firm said in a disclosure to the Qatar Stock Exchange. That works out to an average price per share\u2026","rel":"","context":"In "M&A WATCH"","block_context":{"text":"M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2022\/3\/91.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":563948,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/07\/29\/compass-raises-rameda-stake-to-15-4\/","url_meta":{"origin":708992,"position":1},"title":"Compass raises Rameda stake to 15.4%","author":"enterpriseam admin","date":"29 July 2021","format":false,"excerpt":"Compass ups stake in Rameda: Rameda Pharma\u2019s largest shareholder Equinox Pharma has raised its stake in the company by 2.7% to 15.4%, the company said in a statement (pdf) last night. Equinox is owned by Compass Investment, which acquired 100% of Rameda in 2011 before listing it on the EGX\u2026","rel":"","context":"In "M&A WATCH"","block_context":{"text":"M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":609582,"url":"https:\/\/enterpriseam.com\/egypt\/2023\/11\/07\/pico-and-kufpec-want-to-invest-usd-119-5-mn-in-gulf-of-suez-exploration-plus-equinox-ups-stake-in-rameda-uae-embassy-move-power-generator-plant\/","url_meta":{"origin":708992,"position":2},"title":"Pico and Kufpec want to invest USD 119.5 mn in Gulf of Suez exploration. PLUS: Equinox ups stake in Rameda, UAE embassy move, power generator plant","author":"enterpriseam admin","date":"7 November 2023","format":false,"excerpt":"The two companies also requested 20-year licenses for the concession","rel":"","context":"In "Also on our Radar"","block_context":{"text":"Also on our Radar","link":"https:\/\/enterpriseam.com\/egypt\/category\/also-on-our-radar\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2023\/11\/332.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":611147,"url":"https:\/\/enterpriseam.com\/egypt\/2023\/12\/03\/taqa-wants-some-of-wataniyas-stations-plus-blominvest-now-owns-more-of-rameda-more-investments-from-geidea\/","url_meta":{"origin":708992,"position":3},"title":"Taqa wants some of Wataniya\u2019s stations. PLUS: Blominvest now owns more of Rameda, more investments from Geidea","author":"enterpriseam admin","date":"3 December 2023","format":false,"excerpt":"Taqa Arabia will submit a binding offer to acquire a number of Wataniya fuel stations","rel":"","context":"In \"ALSO ON OUR RADAR\"","block_context":{"text":"ALSO ON OUR RADAR","link":"https:\/\/enterpriseam.com\/egypt\/tag\/also-on-our-radar\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2023\/12\/34.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":546085,"url":"https:\/\/enterpriseam.com\/egypt\/2022\/04\/27\/pif-subsidiary-ups-stake-in-egx-listed-rameda-el-garhy-buys-natl-glass-and-crystal-from-adib-egypt\/","url_meta":{"origin":708992,"position":4},"title":"PIF subsidiary ups stake in EGX-listed Rameda + El Garhy buys Nat\u2019l Glass and Crystal from ADIB Egypt","author":"enterpriseam admin","date":"27 April 2022","format":false,"excerpt":"Saudi PIF subsidiary ups stake in Rameda: The Saudi Seventh Investment Company (SSIC) has purchased another 6.5% of Rameda Pharma, raising its total stake to 11.01%, the EGX announced (pdf) yesterday. SSIC, a subsidiary of the Public Investment Fund (PIF, KSA\u2019s sovereign wealth fund), purchased 65 mn shares for EGP\u2026","rel":"","context":"In "M&A WATCH"","block_context":{"text":"M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":591422,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/05\/rameda-pharma-retail-subscription-surges-on-final-day-offering-closes-33x-oversubscribed\/","url_meta":{"origin":708992,"position":5},"title":"Rameda Pharma retail subscription surges on final day, offering closes 33x oversubscribed","author":"enterpriseam admin","date":"5 December 2019","format":false,"excerpt":"Retail appetite for Rameda\u2019s IPO surgest on last day; offering closing 36.3x oversubscribed: Retail investors poured into Rameda Pharma\u2019s 5% public offering on the final day of subscription yesterday, leading the retail component to close 36.3x oversubscribed, Al Mal reports. Investors had placed orders for 683.22 mn shares by the\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/708992","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=708992"}],"version-history":[{"count":1,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/708992\/revisions"}],"predecessor-version":[{"id":709031,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/708992\/revisions\/709031"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/708987"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media\/708993"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=708992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=708992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=708992"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=708992"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=708992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}